CSF1R and neoplasm: In a later study, colony stimulating factor-1 receptor silencing siRNA was co-delivered with PI3K inhibitor, BEZ-235 using an M2 tumor-associated macrophage targeting nanomicelle to elicit therapeutic immune responses against pancreatic cancer cells both in vitro and in tumor models [101].